18,017 Shares in Tenet Healthcare Co. (NYSE:THC) Acquired by FORA Capital LLC

FORA Capital LLC acquired a new stake in shares of Tenet Healthcare Co. (NYSE:THC - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 18,017 shares of the company's stock, valued at approximately $2,274,000.

Several other institutional investors have also bought and sold shares of the business. Geode Capital Management LLC lifted its position in Tenet Healthcare by 3.5% during the fourth quarter. Geode Capital Management LLC now owns 2,116,121 shares of the company's stock valued at $268,591,000 after purchasing an additional 71,454 shares during the last quarter. Norges Bank bought a new stake in shares of Tenet Healthcare in the 4th quarter worth about $190,819,000. Dimensional Fund Advisors LP lifted its holdings in shares of Tenet Healthcare by 22.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,493,532 shares of the company's stock worth $188,524,000 after acquiring an additional 272,906 shares during the last quarter. AQR Capital Management LLC lifted its holdings in shares of Tenet Healthcare by 20.8% in the 4th quarter. AQR Capital Management LLC now owns 872,117 shares of the company's stock worth $110,087,000 after acquiring an additional 150,361 shares during the last quarter. Finally, Northern Trust Corp lifted its holdings in shares of Tenet Healthcare by 22.0% in the 4th quarter. Northern Trust Corp now owns 848,049 shares of the company's stock worth $107,049,000 after acquiring an additional 152,671 shares during the last quarter. Institutional investors own 95.44% of the company's stock.

Insider Activity

In other news, Director J Robert Kerrey sold 9,525 shares of the firm's stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the sale, the director now directly owns 27,378 shares in the company, valued at approximately $3,434,022.54. This trade represents a 25.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.81% of the company's stock.

Wall Street Analyst Weigh In

THC has been the subject of several analyst reports. Barclays raised their target price on shares of Tenet Healthcare from $161.00 to $171.00 and gave the stock an "overweight" rating in a report on Wednesday, April 30th. Guggenheim started coverage on shares of Tenet Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $165.00 price target on the stock. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $177.00 price target on shares of Tenet Healthcare in a research note on Thursday, February 13th. Baird R W downgraded shares of Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Finally, UBS Group raised their price target on shares of Tenet Healthcare from $217.00 to $230.00 and gave the stock a "buy" rating in a research note on Wednesday, April 30th. Four equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $173.69.

Tenet Healthcare Stock Down 0.2%

NYSE THC traded down $0.26 during trading on Friday, reaching $148.80. 966,210 shares of the company's stock traded hands, compared to its average volume of 1,537,293. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70. The firm has a market cap of $13.82 billion, a price-to-earnings ratio of 4.62, a price-to-earnings-growth ratio of 1.02 and a beta of 1.63. The company's 50 day simple moving average is $129.38 and its two-hundred day simple moving average is $135.83. Tenet Healthcare Co. has a 12-month low of $109.82 and a 12-month high of $171.20.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its earnings results on Tuesday, April 29th. The company reported $4.36 EPS for the quarter, beating analysts' consensus estimates of $3.11 by $1.25. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. The business had revenue of $5.22 billion for the quarter, compared to the consensus estimate of $5.15 billion. During the same quarter last year, the firm posted $3.22 EPS. The company's revenue for the quarter was down 2.5% on a year-over-year basis. As a group, sell-side analysts forecast that Tenet Healthcare Co. will post 12.24 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.